tiprankstipranks
InnoCare Pharma Ltd. (HK:9969)
:9969
Hong Kong Market
9969
InnoCare Pharma Ltd.
RESEARCH TOOLSreports

InnoCare Pharma Ltd. (9969) Income Statement

2 Followers

InnoCare Pharma Ltd. Income Statement

Last quarter (Q4 2025), InnoCare Pharma Ltd.'s total revenue was ¥1.24B, an increase of 298.14% from the same quarter last year. In Q4, InnoCare Pharma Ltd.'s net income was ¥696.46M. See InnoCare Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 2.30B¥ 1.01B¥ 738.54M¥ 625.40M¥ 1.04B
Gross Profit
¥ 2.01B¥ 871.01M¥ 610.10M¥ 482.01M¥ 977.37M
Operating Expenses
¥ 1.57B¥ 1.40B¥ 1.26B¥ 1.25B¥ 1.14B
Depreciation and Amortization
¥ 115.29M¥ 57.99M¥ 92.62M¥ 68.40M¥ 33.71M
EBITDA
¥ 555.89M¥ -463.49M¥ -516.55M¥ -808.28M¥ 16.23M
Operating Income
¥ 440.59M¥ -525.78M¥ -651.15M¥ -770.40M¥ -181.10M
Other Income/Expenses
¥ 198.18M¥ 73.19M¥ 6.95M¥ -123.32M¥ 160.98M
Pretax Income
¥ 638.77M¥ -452.59M¥ -644.21M¥ -893.73M¥ -20.12M
Net Income
¥ 625.84M¥ -440.63M¥ -631.26M¥ -886.59M¥ -64.55M
Per Share Metrics
Basic EPS
¥ 0.36¥ -0.26¥ -0.37¥ -0.60¥ -0.05
Diluted EPS
¥ 0.36¥ -0.26¥ -0.37¥ -0.60¥ -0.05
Weighted Average Shares Outstanding
 1.76B 1.69B 1.71B 1.48B 1.37B
Weighted Average Shares Outstanding (Diluted)
 1.76B 1.69B 1.71B 1.48B 1.37B
Currency in CNY

InnoCare Pharma Ltd. Earnings and Revenue History